Revna Biosciences
Revna Biosciences is a pioneering biotechnology company dedicated to advancing precision medicine and molecular diagnostics in Ghana and West Africa. They focus on personalized treatment solutions, genetic profiling, targeted therapies, clinical research, and diagnostic services to improve patient outcomes, especially in cancer care. Their mission is to unravel the biological underpinnings of diseases affecting Africans and the global population, leveraging cutting-edge technology and strategic alliances.
Industries
Nr. of Employees
small (1-50)
Revna Biosciences
5 Nii Kwei Okang Mensah Street, Nmai Dzorn, Accra, Ghana
Services
Laboratory-based molecular assays for detection of clinically relevant genetic alterations to support diagnosis and treatment selection.
Comprehensive sequencing and expression profiling of patient samples to identify molecular drivers of disease.
Collection, storage, and custodianship of biospecimens according to biobanking standards to support research and diagnostics.
Operational support for clinical studies including protocol execution, participant selection, and trial oversight.
Educational workshops and training to equip clinicians and laboratory staff with skills for biomarker testing and precision medicine implementation.
Programs and materials to inform patients about precision medicine options and support engagement in care decisions.
Laboratory-based molecular assays for detection of clinically relevant genetic alterations to support diagnosis and treatment selection.
Comprehensive sequencing and expression profiling of patient samples to identify molecular drivers of disease.
Collection, storage, and custodianship of biospecimens according to biobanking standards to support research and diagnostics.
Operational support for clinical studies including protocol execution, participant selection, and trial oversight.
Educational workshops and training to equip clinicians and laboratory staff with skills for biomarker testing and precision medicine implementation.
Programs and materials to inform patients about precision medicine options and support engagement in care decisions.
Expertise Areas
- Precision medicine
- Genomic profiling and analysis
- Molecular diagnostics
- Biobanking and specimen management
Key Technologies
- Next-generation sequencing (NGS)
- Molecular diagnostic assays (DNA/RNA/protein)
- Biobanking and cold-chain specimen management
- Central laboratory sample processing
News & Updates
Genomic research has emerged as a transformative field, revolutionizing our understanding of human health and genetics. Ghana has positioned itself as a leading hub for genomic research on the African continent.
Revna Biosciences is advancing cancer treatment in Ghana through precision medicine, offering targeted therapies tailored to individual patients, and collaborating with partners like AstraZeneca to enhance diagnostic capabilities.
Genomic research has emerged as a transformative field, revolutionizing our understanding of human health and genetics. Ghana has positioned itself as a leading hub for genomic research on the African continent.
Revna Biosciences is advancing cancer treatment in Ghana through precision medicine, offering targeted therapies tailored to individual patients, and collaborating with partners like AstraZeneca to enhance diagnostic capabilities.